Keith S. Ehrlich

2013

In 2013, Keith S. Ehrlich earned a total compensation of $763.9K as Vice President, Finance and Administration, Chief Financial Officer at Synta Pharmaceuticals, a 22% increase compared to previous year.

Compensation breakdown

Bonus$68,000
Option Awards$406,580
Salary$281,667
Other$7,650
Total$763,897

Ehrlich received $406.6K in option awards, accounting for 53% of the total pay in 2013.

Ehrlich also received $68K in bonus, $281.7K in salary and $7.7K in other compensation.

Rankings

In 2013, Keith S. Ehrlich's compensation ranked 7,770th out of 12,286 executives tracked by ExecPay. In other words, Ehrlich earned more than 36.8% of executives.

ClassificationRankingPercentile
All
7,770
out of 12,286
37th
Division
Manufacturing
2,810
out of 4,612
39th
Major group
Chemicals And Allied Products
870
out of 1,462
41st
Industry group
Drugs
658
out of 1,156
43rd
Industry
Pharmaceutical Preparations
521
out of 890
42nd
Source: SEC filing on April 30, 2014.

Ehrlich's colleagues

We found five more compensation records of executives who worked with Keith S. Ehrlich at Synta Pharmaceuticals in 2013.

2013

Sumant Ramachandra

Synta Pharmaceuticals

Former President, Research and Development

2013

Safi Bahcall

Synta Pharmaceuticals

Chief Executive Officer

2013

Vojo Vukovic

Synta Pharmaceuticals

Chief Medical Officer

2013

Amar Singh

Synta Pharmaceuticals

Former Senior Vice President, Chief Business Officer

2013

Steven Bernitz

Synta Pharmaceuticals

Senior Vice President, Chief Business Officer

In-depth

You may also like